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Tetrazoles are a class of organic compound often used as 
carboxylic acid analogues. This anologous behaviour is shown to 
extend to crystallization modification, that is, tetrazoles are also 
able to influence crystal growth and morphology although in a 
different manner to their carboxylate counterparts. All tetrazoles 10 
investigated thus far are shown to impact on barium sulfate and 
calcium carbonate crystallization to varying degrees. Thus, the 
tetrazoles represent a new class of crystal modifier.  
The investigation of crystallization is an active field, with 
much literature focussed on the impact that impurities or 15 
additives have on that process (for some reviews see 1-3). 
Crystallization control is desirable for many reasons, 
including controlling physical properties such as size and 
shape, complete inhibition (scale control), or growth 
acceleration for more efficient processing.1, 2 Thus, additives 20 
or impurities are a means of enforcing some control over the 
crystallization processes occuring. To this end, many 
additives or impurities have been investigated to date, ranging 
from small molecules,3 to polymeric species4 and even to 
biological species.5 It is an area that we too, have been 25 
interested in, looking at factors such as the impact of 
stereochemistry,6 and functional groups,7 amongst others. 
Phosphonates are considered the most potent inhibitors, 
followed by sulfonates and carboxylates though this is 
tempered by other factors such as stereochemistry etc.8 In this 30 
manuscript we present a new class of crystal growth modifier 
that to the authors’ knowledge has never before used to 
modify crystallization, the tetrazoles. 
 
Over the past decades, methodologies to prepare tetrazole 35 
rings as well as the synthesis of tetrazole-containing 
compounds have been extensively investigated.9-11 The wide 
interest in this particular heterocycle stems from its many 
applications. The peculiar coordination chemistry of the 
tetrazolate anion has been exploited for the preparation of 40 
coordination complexes12-14 and metal-organic frameworks15, 
16 of transition metals and, more recently, lanthanoid 
elements.17-19 Tetrazoles have been exploited as analogues of 
carboxylic acids in medicinal chemistry formulations with 
antifungal, antibacterial, anticancer, as well as anti-45 
neurodegenerative activities.20 In fact, the similar pKa of 
these two functional groups21 means the tetrazole ring can be 
utilised as a more metabolically stable (hence more 
biocompatible) surrogate of a carboxylic acid group. Figure 1 
shows the structures of the tetrazole derivatives investigated 50 




Fig. 1 The tetrazole derivatives investigated in this work, 1H-tetrazol-5-55 
yl)benzene (phtetH), methyl 4-(1H-tetrazol-5-yl)benzoate (mbtetH), 4-
(1H-tetrazol-5-yl)benzaldehyde (bztetH), and 1,4-bis(1H-tetrazol-5-
yl)benzene (phtet2H2) 
 
All of these tetrazoles were prepared according to published 60 
procedures,10 by addition of NaN3 to the corresponding nitrile 
in presence of triethylammonium chloride. The tetrazoles 
were investigated at a concentration range of 0 – 1 g/L. The 
crystal growth experiments were carried out as described 
previously.7 In the case of barium sulfate, the crystallization 65 
process involved the standard addition of barium chloride to 
sodium sulfate, while for calcium carbonate the diffusion 
method (carbon dioxide diffusing into a calcium chloride 
solution) was employed (further details can be obtained in the 
supplementary information).   70 
 
Figure 2 shows the impact of the various tetrazole additives 




Fig. 2 SEM images of barium sulfate formed in the presence of (a) 0 
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It can be seen that the presence of phtet- during barium 
sulfate crystallization results in particles with a larger aspect 
ratio (Figure 2b) but interestingly a rough, seemingly porous 
(100) face is also observed (see supporting information, 5 
SIFig1). This was found to a much lesser extent when bztet- 
was present (see supporting information, SIFig2), the particles 
almost being equivalent to the control particles. The presence 
of mbtet- also resulted in barium sulfate with a larger aspect 
ratio (Figure 2c). The addition of phtet22- to growing barium 10 
sulfate showed the greatest impact with thick rhombohedral 
rods being formed (Figure 2d). These results show that 
tetrazole derivatives do have an impact on crystal growth, and 
that the chemical functionality of the additive does influence 
the nature of that impact. 15 
 
The larger aspect ratio observed for barium sulfate formed in 
the presence of all of the tetrazole molecules investigated here 
suggests a promotion of growth on the (001) relative to the 
other faces,1 thus the tetrazoles appear to be promoting barium 20 
sulfate crystallization (at least on the (001) face relative to the 
other morphological faces present). The results obtained with 
phtet2H2 can be contrasted with our previous work with the 
analogous carboxylate, terephthalic acid,3 which produced no 
elongation of the barite crystals, but instead a mixture of 25 
crystals comparable to those found in the blank, along with 
clusters of smaller platelets, albeit at lower additive 
concentrations.  
  
  30 
  
Fig. 3 Calcium carbonate crystallized in the presence of (a) 0mM 
tetrazoles (b) 1.71 mM phtet- (c) 1.44 mM bztet- and (d) 1.24 mM 
phtet22- 
 35 
The presence of the various tetrazoles also has a significant 
impact on calcium carbonate crystallization (Figure 3). The 
presence of phtet-, bztet- and phtet22- (see supporting 
information for calcium carbonate crystallized in the presence 
of mbtet-, SIFig 3) results in an impact typical of many 40 
calcite inhibitors with rounding of the corners, compared to 
the typical rhombohedra observed in the blank (Figure 3a).22 
The presence of bztet-, however, results in the stabilisation of 
hexagonal vaterite (confirmed with Raman spectroscopy, see 
supporting information SIFig. 4). Normally, vaterite is 45 
observed as a transient species before the thermodynamic 
product (calcite) crystallises. Some additives, however, are 
known to stabilise vaterite.23 Finally, the tetrazoles appear to 
be more potent inhibitors of calcium carbonate crystallization 
than the simple carboxylate-containing amino acids, which 50 
require ~10 mM for effects to be observed5 and also more 
potent than their carboxylic acid counterparts, though this 
needs to be verified due to concentration differences in the 
two studies.3 Tetrazole bztet- appears to specifically inhibit 
calcite formation and/or stabilize vaterite formation. 55 
 
It can be conclusively stated that the tetrazole functionality 
has an effect on crystallization since in phtet- and phtet22- no 
other functional moieties are present. In addition, the increase 
in the number of tetrazole groups from one to two shows an 60 
increased impact on morphology as would be expected based 
on the typical behaviour of more established carboxylate and 
phosphonate-based systems.1 Finally, morphology 
experiments in the presence of sodium chloride at 
concentrations in excess of those used in this study (even 65 
accounting for the 2 tetrazole groups in phtet22-) show that 
these effects are not due to the presence of sodium or chloride 
ions (see supplementary information SIFig 5). We hypothesise 
that the action of the tetrazole involves the nitrogen atoms as 
well as an electrostatic interaction and we are pursuing this 70 
with further experimental and modelling investigations. 
 
In conclusion, a new class of crystal modifiers, the tetrazoles, 
has been presented in this manuscript. This broadens the 
‘toolkit’ of the scientist aiming to design additives to control 75 
crystallization, adding a new functional group to the more 
widely used anionic moieties such as carboxylates and 
phosphonates. Furthermore, while the tetrazoles are often used 
as analogues of carboxylates in various fields, tetrazole-based 
crystal growth modifiers appear to have the potential to be 80 
significantly more potent than comparable carboxylates. 
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